NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies

Por Hilal S. Khalil, Simon P. Langdon, Ibrahim H. Kankia, James Bown, Yusuf Y. Deeni
Publicado em 2016-01-01

Systems Analysis of Drug-Induced Receptor Tyrosine Kinase Reprogramming Following Targeted Mono- and Combination Anti-Cancer Therapy

Por Alexey Goltsov, Yusuf Deeni, Hilal S. Khalil, Tero Soininen, Stylianos Kyriakidis, Huizhong Hu, Simon P. Langdon, David J. Harrison, James Bown
Publicado em 2014-06-01

Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer

Por James Meehan, Mark Gray, Mark Gray, Carlos Martínez-Pérez, Carlos Martínez-Pérez, Charlene Kay, Lisa Y. Pang, Jennifer A. Fraser, Amy V. Poole, Ian H. Kunkler, Simon P. Langdon, David Argyle, Arran K. Turnbull, Arran K. Turnbull
Publicado em 2020-04-01